Vifor Pharma AG
ISIN: CH0364749348 | Ticker: VIFN | LEI: 529900KO6CN2D9OE1F19
Country: Switzerland
Vifor Pharma is a world leader in the discovery, development, manufacturing and marketing of pharmaceutical products for the treatment of iron deficiency. The company also offers a diversified portfolio of prescription medicines as well as non-prescription medicines. The Group also has a focus on the management of conditions in nephrology, cardiology and rare diseases.
Vifor Pharma's operational headquarters are in Zurich, Switzerland, and the company has an increasingly global presence and a broad network of affiliates and partners around the world.
1927
Served areaWorldwide
Headcount2,600
HeadquartersRechenstrasse 37, 9014 St. Gallen – Switzerland
| Date | Trading entity / Person | Association | Trade type | Volume |
|---|---|---|---|---|
| 09.03.22 | None | Executive member | Sell | CHF 4,335,210.00 |
| 09.03.22 | None | Non-Executive member | Sell | CHF 1,951,125.00 |
| 09.03.22 | None | Non-Executive member | Sell | CHF 1,851,300.00 |
| 09.03.22 | None | Executive member | Sell | CHF 1,535,160.00 |
| 09.03.22 | None | Non-Executive member | Sell | CHF 1,450,515.00 |
| 09.03.22 | None | Executive member | Sell | CHF 920,205.00 |
| 09.03.22 | None | Executive member | Sell | CHF 530,310.00 |
| 09.03.22 | None | Non-Executive member | Sell | CHF 382,140.00 |
| 09.03.22 | None | Non-Executive member | Sell | CHF 330,495.00 |
| 09.03.22 | None | Executive member | Sell | CHF 287,925.00 |
CH0364749348
LEI529900KO6CN2D9OE1F19
SectorPharmaceuticals, Biotechnology & Life Sciences
IndustryKeep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.